Skip to main content
. 2022 Aug 22;37(9):1948–1952. doi: 10.1002/mds.29145

TABLE 1.

Clinical and treatment features

Case Age at symptoms onset, y Clinical features at disease onset Clinical features at treatment onset Duration of symptoms before treatment onset Duration since treatment initiation Treatment benefit Treatment discontinuation
1 26 Foot dystonia Dysphagia, dysarthria, oro‐facial dystonia, chorea of upper limb, mild cerebellar signs 33 y 62 m Benefit: +, slight improvement of the last sign that appeared: apathy Duration of 8 m with rapid degradation
2 46 Cerebellar syndrome Cerebellar and extra‐pyramidal syndrome 11 y 141 m Benefit: ++, mild improvement (UPDRS scores from 26 to 19) 30 m with worsening of gait, balance, extrapyramidal syndrome, depression, apparition of dystonia
3 28 Spastic paraparesis Spastic paraparesis 3 y 122 m Benefit: +++, from 1 km to unlimited walking range 41 m with worsening of spastic paraplegia
4 48 Extra‐pyramidal and cerebellar syndrome Extra‐pyramidal and cerebellar syndrome 4 y 41 m Benefit: ++++, improvement of cerebellar signs (SARA from 10 to 4) No discontinuation

y = years; m = month.